PREMIER Biosoft International Releases TMA Foresight, a Statistical Tool for Tissue Microarray Data Analysis.
Palo Alto, California -- January 15, 2007,
PREMIER Biosoft International today announced the release
of its new product, TMA Foresight. TMA Foresight is
a statistical tool for tissue microarray data analysis
designed especially for pathologists, clinicians and
TMA Foresight can be used for a wide variety of analysis
ranging from simple descriptive statistics that include
mean, sum, and variance to more advanced data correlation
such as Hierarchical clustering and Kaplan Meier plots.
You can explore the relatedness of prognostic marker
expression and clinico-pathological variates with the
outcome. Cox's Proportional Hazard analysis can be used
for prognostic marker identification. Hierarchical clustering
can be used to group patients on the basis of a clinico-pathological
parameter or a biomarker. Kaplan-Meier plots and log-rank
tests can then be used to identify prognostically significant
clusters. You can threshold a particular marker and stratify patients into high risk and low risk cohorts.
TMA Foresight not only analyzes data but interprets
it, making it a useful tool for pathologists, clinicians
TMA Foresight enables easy data pre-processing. It
helps map the character data to numeric values with
a click of a button. Moreover, the measurement level
of each variable can be conveniently defined for use
in different statistical analysis.
For details, please visit: http://www.premierbiosoft.com/tissue-microarray/index.html